Please login to the form below

Not currently logged in
Email:
Password:

Plethora

This page shows the latest Plethora news and features for those working in and with pharma, biotech and healthcare.

Neurodegenerative disorders market set to reach $45bn by 2022

Neurodegenerative disorders market set to reach $45bn by 2022

The majority of this growth is expected to take place from 2018, when a plethora of late-stage products are due to be submitted for regulatory approval.

Latest news

  • Overriding the main frame Overriding the main frame

    It is better to have a plethora of great ideas to whittle down and prioritise later vs.

  • Explosive evolution Explosive evolution

    Most patients and payers, whatever their clinical and economic needs, will have many good and varied options to choose from, so most companies will have to compete against this plethora of

  • Money-back guarantee Money-back guarantee

    Despite the best designed RCTs, the plethora of real world experience, the input of peers and the development of evidence-based guidelines, the truth is that sometimes we simply don't

  • US seeking price cuts for Medicare drugs US seeking price cuts for Medicare drugs

    provision. A plethora of new drugs for cancer and other diseases are reaching the market that cost well upwards of $100, 000 a year, while the $1, 000-a-day price

  • US seeking price cuts for Medicare drugs US seeking price cuts for Medicare drugs

    provision. A plethora of new drugs for cancer and other diseases are reaching the market that cost well upwards of $100, 000 a year, while the $1, 000-a-day price

More from news
Approximately 1 fully matching, plus 70 partially matching documents found.

Latest Intelligence

  • The valuable brand The valuable brand

    Value creating activity. One aspect of brand strategy that has not changed in decades is the plethora of choice for brand managers.

  • Gene therapy Gene therapy

    In oncology, there was already a plethora of seemingly obvious targets, as our knowledge of oncogenes driving different cancers expanded.

  • Humanisation Humanisation

    This plethora of talent allows us to develop and improve our communications offerings.

  • Customer experience rules the digital age Customer experience rules the digital age

    articles, news stories, discussions with family and friends, not to mention the healthcare system and the plethora of professionals who are seen, such as doctors, nurses, pharmacists, etc.

  • Choosing destiny Choosing destiny

    This newly complex landscape, summarised in figure 1, means a plethora of choices for industry strategists and makes it all the more important that they choose their future business model carefully.

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics